Location History:
- Reading, GB (2011)
- Caversham, Reading, GB (2011)
Company Filing History:
1 out of 1 
1 out of 832,843 Years Active: 2011
Title: Catherine M Radcliffe: Innovator in Glycosylation Marker Identification
Introduction
Catherine M Radcliffe is a prominent inventor based in Reading, GB. She has made significant contributions to the field of glycosylation marker identification, holding 2 patents that focus on innovative strategies for diagnosing and monitoring physiological conditions, particularly cancer.
Latest Patents
Radcliffe's latest patents include an automated strategy for identifying physiological glycosylation markers. This invention allows for the identification and quantification of glycosylation markers associated with various physiological conditions, including diseases. The method utilizes quantitative HPLC analysis of glycans released from unpurified glycoproteins, which can be either total glycoproteins or a selection thereof. The identified glycosylation markers can be native glycans or digestion products that have been amplified through exoglycosidase digestions. This high-throughput strategy is compatible with glycan database searching and can be utilized for monitoring physiological conditions in subjects. Additionally, her patent on glycosylation markers for cancer diagnosing and monitoring employs similar techniques to identify and quantify glycosylation markers specifically related to cancer, aiding in the diagnosis and monitoring of the disease.
Career Highlights
Throughout her career, Radcliffe has worked with notable organizations, including the National Institute for Bioprocessing Research and Training Limited (NIBRT). Her work has significantly advanced the understanding of glycosylation markers and their applications in medical diagnostics.
Collaborations
Radcliffe has collaborated with esteemed colleagues such as Raymond A Dwek and Louise Royle, contributing to the advancement of research in her field.
Conclusion
Catherine M Radcliffe's innovative work in glycosylation marker identification has paved the way for advancements in disease diagnosis and monitoring. Her contributions continue to impact the field of bioprocessing and medical research.